INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Birchview Capital, LP's Holding History (CIK: 0001618205)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 8,300 Value ($000) $344 Avg Close — Range —
Q2 2020
Shares 8,300 Value ($000) $398 Avg Close — Range —
Q1 2020
Shares 8,300 Value ($000) $523 Avg Close — Range —
Q4 2019
Shares 8,300 Value ($000) $1,029 Avg Close — Range —
Q3 2019
Shares 8,300 Value ($000) $551 Avg Close — Range —
Q2 2019
Shares 8,300 Value ($000) $660 Avg Close — Range —
Q1 2019
Shares 8,300 Value ($000) $928 Avg Close — Range —
Q4 2018
Shares 4,300 Value ($000) $433 Avg Close — Range —
Q3 2018
Shares 4,300 Value ($000) $543 Avg Close — Range —
Q2 2018
Shares 4,300 Value ($000) $361 Avg Close — Range —
Q1 2018
Shares 4,300 Value ($000) $265 Avg Close — Range —
Q4 2017
Shares 4,300 Value ($000) $251 Avg Close — Range —
Q3 2017
Shares 4,300 Value ($000) $250 Avg Close — Range —
Q3 2016
Shares 1,300 Value ($000) $214 Avg Close — Range —
Q2 2016
Shares 1,300 Value ($000) $185 Avg Close — Range —
Q1 2016
Shares 1,300 Value ($000) $167 Avg Close — Range —